| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/23/2005 | WO2005031359A3 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep (rnpep) |
| 06/23/2005 | WO2005030947A3 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases |
| 06/23/2005 | WO2005030119A3 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| 06/23/2005 | WO2005030032A3 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
| 06/23/2005 | WO2005029086A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a10 (ust3-like2) (slc22a10) |
| 06/23/2005 | WO2005029085A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a11 (slc22a11) |
| 06/23/2005 | WO2005028096A9 Microfluidics devices and methods for performing cell based assays |
| 06/23/2005 | WO2005026737A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a4 (slc22a4) |
| 06/23/2005 | WO2005024423A3 A method for qualitative and/or quantitative detection of polyethylene glycols in biological fluids |
| 06/23/2005 | WO2005023232A3 Therapeutic, screening and diagnostic methods based on the effect of cb1 receptor modulation on lymphoproliferative disorders. |
| 06/23/2005 | WO2005018436A8 Methods for the diagnosis, prognosis and treatment of metabolic syndrome |
| 06/23/2005 | WO2005015205A3 Use of sap |
| 06/23/2005 | WO2005003298A3 Surrogate therapeutic endpoint for anti-ctla-4 based immunotherapy of disease |
| 06/23/2005 | WO2005002505A3 Apolipoprotein c-1 induced apoptosis |
| 06/23/2005 | WO2004111663A3 System for generating and using biological qualification slides to qualify biological screening devices |
| 06/23/2005 | WO2004098521A3 Treatment and diagnostics of cancer |
| 06/23/2005 | WO2004096855A3 Methods utilising g-protein coupled receptor 54 |
| 06/23/2005 | WO2004096142A3 Alk protein tyrosine kinase, cells and methods embodying and using same |
| 06/23/2005 | WO2004089369B1 Methods and means for treating protein conformational disorders |
| 06/23/2005 | WO2004081535A3 The establishment of proteome structure profile databases and their uses |
| 06/23/2005 | WO2004080373A3 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) |
| 06/23/2005 | WO2004078928A3 T cell regulation |
| 06/23/2005 | WO2004072638A8 Non-invasive assessment of intra-amniotic environment |
| 06/23/2005 | WO2004069737A3 Articles with dispersed conductive coatings |
| 06/23/2005 | WO2004052184A3 Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| 06/23/2005 | WO2004046731A3 Method for analysing amino acids, peptides and proteins using mass spectroscopy of fixed charge-modified derivatives |
| 06/23/2005 | WO2004018997A3 Methods and compositions for modulating amyloid beta |
| 06/23/2005 | WO2004017443A3 Electrochemical cells, and gas sensor and fuel cell devices comprising same |
| 06/23/2005 | WO2004000999A3 Identification of a receptor controlling migration and metastasis of skin cancer cells |
| 06/23/2005 | WO2003106639A8 Recombination of nucleic acid library members |
| 06/23/2005 | WO2003102163A8 Methods of diagnosing and treating diabetes and insulin resistance |
| 06/23/2005 | WO2003056896A3 Use of cytokines secreted by dendritic cells |
| 06/23/2005 | US20050138676 Identification of genes involved in Alzheimer's disease using Drosophila melanogaster |
| 06/23/2005 | US20050137808 Method for conceptualizing protein interaction networks using gene ontology |
| 06/23/2005 | US20050137807 Using computreized an indication-specific target profile |
| 06/23/2005 | US20050137806 Characterizing biological stimuli by response curves |
| 06/23/2005 | US20050137805 Gene expression profiles that identify genetically elite ungulate mammals |
| 06/23/2005 | US20050137470 Method and apparatus for low blood glucose level detection |
| 06/23/2005 | US20050137388 Real-time nucleic acid detection processes and compositions |
| 06/23/2005 | US20050137334 Composite nanospheres and their conjugates with biomolecules |
| 06/23/2005 | US20050137218 Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
| 06/23/2005 | US20050137159 Methods compositions and articles of manufacture for modulating bone growth |
| 06/23/2005 | US20050137158 Methods for targeting RNA molecules |
| 06/23/2005 | US20050137137 Inhibitors of the Interaction between p53 and MDM2 |
| 06/23/2005 | US20050137128 Modulators of ß-amyloid peptide aggregation |
| 06/23/2005 | US20050137112 determining lymphocyte epitopes in proteins comprising obtaining from blood, a solution of dendritic cells and CD4 antigens, then promoting cell differentiation, by exposing to cytokines, then mixing with peptides of interest and measuring the proliferation of lymphocytes |
| 06/23/2005 | US20050136552 Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| 06/23/2005 | US20050136551 Micro mechanical methods and systems for performing assays |
| 06/23/2005 | US20050136550 Flow control of electrochemical-based assay devices |
| 06/23/2005 | US20050136549 Method and system for automatically determining diagnostic saliency of digital images |
| 06/23/2005 | US20050136548 Apparatus for detection and analysis of nucleic acids in blood; gene expression analysis; discriminating between the components of mixtures comprising, toxins, bacteria and food |
| 06/23/2005 | US20050136545 Centripetally-motivated microsystems platform comprising microfluidic structure, rotatable platform and reservoirs for use in miniaturized cell based assays; hepatocytes and drug screening |
| 06/23/2005 | US20050136543 Using osmotic pressure changes to determine presence or absence of reaction between a first and second material |
| 06/23/2005 | US20050136542 Stabilized liquid reference solutions |
| 06/23/2005 | US20050136541 Cartridge for monitoring the function of a device for testing blood platelet function, method for function monitoring, and use of a test fluid |
| 06/23/2005 | US20050136539 Generating immortalized human renal proximal tubule epithelial cell (RPTEC) for use as model for identifying modulators of renal toxicity |
| 06/23/2005 | US20050136533 Evaluating sample on microarray so as not to cause deviation of site positions during measurement; microarrays |
| 06/23/2005 | US20050136532 System of scattering surface plasmon resonance for detecting a target |
| 06/23/2005 | US20050136529 Laminated assay devices |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136514 Related to sodium/glucose cotransporter subfamily; drug screening; biochips; host cells |
| 06/23/2005 | US20050136509 Apparatus which utilizes digtal image analysis and immunohistochemical staining as tool in classification, diagnosis and prognosis of cancer |
| 06/23/2005 | US20050136506 electrooptical method for quantifying motility response of cells to external stimuli, wherein target cell population (formed as a function of said response) is subsequently optically differentiated by addition of optical differentiation solution |
| 06/23/2005 | US20050136503 Fluorescent pH indicators for intracellular assays |
| 06/23/2005 | US20050136502 Treatment of disorders associated with elevated blood glucose or blood pressure |
| 06/23/2005 | US20050136501 Biosensor strip for use in determining concentration of glucose in blood |
| 06/23/2005 | US20050136500 Flow-through assay devices |
| 06/23/2005 | US20050136499 Control plasma for thrombin activity tests |
| 06/23/2005 | US20050136498 Using pregnancy-associated plasma protein-A (PAPP-A) as diagnostic indicator of cardiovascular and atherosclerotic disorders |
| 06/23/2005 | US20050136497 Assay buffer, compositions containing the same, and methods of using the same |
| 06/23/2005 | US20050136496 Detecting and classifying transient ischemic events using presence of thrombomodulin, myelin basic proteins, S100 protein and neuronal specific enolase markers in cerebrospinal fluids |
| 06/23/2005 | US20050136495 Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae |
| 06/23/2005 | US20050136493 Using immunoglobulin to detect alpha -methylacyl-CoA racemase (AMACR) in urine; immunodiagnostic and cell proliferative disorders |
| 06/23/2005 | US20050136492 Such as caspases and serine proteases, for determining apoptotic state of a cell, detecting presence of tumor (cancer) cells, predicting efficacy of chemotherapy, and determining the probability of graft rejection or acceptance |
| 06/23/2005 | US20050136491 Method of site specific labeling of proteins and uses therefor |
| 06/23/2005 | US20050136490 Using presence of insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal/cervicaal secretions as diagnostic indicator for preterm labor; immunoassay |
| 06/23/2005 | US20050136489 Biomarkers for liver diseases and method for using the same |
| 06/23/2005 | US20050136488 Identifying population of cells expressing fusion protein construct via fluorescent signal; diagnosing cancer |
| 06/23/2005 | US20050136487 Transmissible spongiform encephalopathy detection in cervids, sheep and goats |
| 06/23/2005 | US20050136486 Methods for optically encoding an object with upconverting materials and compositions used therein |
| 06/23/2005 | US20050136485 Iterative one-pot oligosaccharide synthesis |
| 06/23/2005 | US20050136483 Preparing receptor-nanofusion for use as targeting tool in monitoring ligand binding interaction; drug targeting and delivery |
| 06/23/2005 | US20050136481 Using computer modeling to predict three dimensional structure of g-protein coupled receptor; sequence determination; monitoring ligand/protein interactions; rational drug design |
| 06/23/2005 | US20050136480 Generating peptide libraries for use as targets in rational drug design; identifying genes using oligopeptides that are found to occur in the open reading frames related genomes |
| 06/23/2005 | US20050136479 Swab-based diagnostic systems |
| 06/23/2005 | US20050136478 Preparing microarray comprising cell surface ligands for use as to in separation and classification of cell types |
| 06/23/2005 | US20050136476 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | US20050136474 Truncation SELEX method |
| 06/23/2005 | US20050136472 Using channel protein as tool in detection of modulators for prevention and treatment of cell proliferative, inflammatory and nervous system disorders |
| 06/23/2005 | US20050136470 Apparatus for detecting biopolymers and cartridge |
| 06/23/2005 | US20050136469 Photon reducing agents for fluorescence assays |
| 06/23/2005 | US20050136468 Methods to diagnose a required regulation of trophoblast invasion |
| 06/23/2005 | US20050136467 Neuregulin fusion comprising epidermal growth factor domain for use in treatment and prevention of nervous system and neurodegenerative disorders |
| 06/23/2005 | US20050136465 Screening assays |
| 06/23/2005 | US20050136464 Quantitation of biomolecule in a complex mixture by serial combinatorial dilution |
| 06/23/2005 | US20050136461 Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers |
| 06/23/2005 | US20050136459 Double adhesive covering comprised of hydrophobic material for use as sealing component in bipolymer array reaction chamber |
| 06/23/2005 | US20050136457 Using sequence specific searches of genome databases to screen for predicted genetic sites and/or chromosomal structures; bioinformatics |
| 06/23/2005 | US20050136455 Using elevated c-reactive protein concentration as diagnostic/prognostic indiactor of diabetes and/or coronary artery disease |